Dr. Mohammed Alshawsh is currently working as Associate Professor at the Department of Pharmacology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia. He obtained his PhD from Faculty of Medicine, the University of Malaya in 2012. After his one-year postdoc at the University of Malaya, he joined Department of Pharmacology, the University of Malaya in 2013. Since then he has been doing preclinical research in the area of metabolic syndrome, cancer and safety pharmacology. His current field of research interest mainly focuses on the pharmacological and toxicological evaluation of natural products for the treatment of colorectal cancer, obesity, diabetes, and fatty liver diseases using in vivo (animal models) and in vitro (cell culture) studies and investigating the gene expression profiling to unravel the underlying molecular mechanisms involved. He is also doing safety and toxicology studies in particular acute, subacute, and chronic toxicities, genotoxicity, teratogenicity and postnatal developmental toxicity. Dr. Alshawsh is a scientist member of Faculty of Medicine-Institutional Animal Care and Use Committee (FOM-IACUC)-University Malaya, Italo-Latin American Society of Ethnomedicine, Laboratory Animal Science Association of Malaysia (LASAM), and Malaysian Society of Pharmacology and Physiology. He serves as Associate Editor for the BMC Complementary and Alternative Medicine Journal. He is also an editorial board member and a reviewer for several international journals. He supervised 2 PhD students to completion; currently, he is supervising 8 PhD students and 1 Master student. He has published over 30 papers in peer-reviewed journals and has given over 15 invited and plenary lectures at international conferences. He has obtained several research grants, such as UMRG, PPP and FRGS and has an h-index of 11 and citations of more than 240 (Scopus).